Key Takeaways
- • SV Investment operates as a Seoul-headquartered venture capital and private equity firm with $1.348 billion in assets under management and a gross IRR track record supporting its positioning as a major VC player across multiple geographies.
- • The firm maintains a diversified portfolio across 20 tracked investments spanning 19 companies, with recent activity including a $60.0 million Series B investment in BreezeBio as of February 2026.
- • SV Investment operates multiple fund vehicles including specialized healthcare funds (SV Health Investors), seed-stage platforms (SV Angel), and short-term note programs, reflecting a multi-stage investment strategy from seed through growth capital.
- • The firm co-invests extensively with peer funds including IMM Investment, suggesting a collaborative syndication approach that allows capital pooling and risk distribution across institutional rounds.
- • SV Investment maintains a global footprint with offices in Seoul, Boston, Shanghai, Shenzhen, and Jakarta, positioning it to access deal flow across North American, Asian, and emerging market venture ecosystems.
Summary
SV Investment is a Seoul-based venture capital and private equity firm that has established itself as a significant player in the global investment landscape with $1.348 billion in assets under management. The firm operates through a diversified platform spanning multiple fund vehicles and geographies, with offices located in Boston, Shanghai, Shenzhen, and Jakarta alongside its Korean headquarters. This geographic footprint reflects a deliberate strategy to capture investment opportunities across developed markets and high-growth emerging regions.
The firm's investment approach spans multiple stages and sectors. SV Investment maintains 20 tracked investments across 19 companies, demonstrating an active portfolio management posture. Notable recent activity includes a $60.0 million Series B investment in BreezeBio in February 2026, indicating continued deployment of growth-stage capital. The firm has also developed specialized investment vehicles including SV Health Investors, a dedicated healthcare-focused private equity and venture capital platform that spans all sectors and stages within healthcare innovation.
SV Investment's capital structure includes multiple vehicle types designed to serve different investor time horizons and risk profiles. The firm operates short-term note programs with 12-month redemption profiles and rollover options, allowing institutional investors flexibility in capital allocation. SV Angel represents the firm's seed-stage investing platform, emphasizing long-term founder relationships and impact-focused outcomes beyond traditional financial returns. Historical portfolio investments have included companies in media and information services, such as FocusVision Worldwide and The Pennysaver.
The firm operates within an active co-investment ecosystem, regularly syndicating deals with other institutional capital providers including IMM Investment, which holds a substantial percentage of overlapping portfolio positions. This syndication approach suggests that SV Investment functions both as a lead investor and as a capital partner in larger rounds, leveraging relationships across the venture and private equity communities to structure investments that meet institutional scale and due diligence requirements.
The firm's investment approach spans multiple stages and sectors. SV Investment maintains 20 tracked investments across 19 companies, demonstrating an active portfolio management posture. Notable recent activity includes a $60.0 million Series B investment in BreezeBio in February 2026, indicating continued deployment of growth-stage capital. The firm has also developed specialized investment vehicles including SV Health Investors, a dedicated healthcare-focused private equity and venture capital platform that spans all sectors and stages within healthcare innovation.
SV Investment's capital structure includes multiple vehicle types designed to serve different investor time horizons and risk profiles. The firm operates short-term note programs with 12-month redemption profiles and rollover options, allowing institutional investors flexibility in capital allocation. SV Angel represents the firm's seed-stage investing platform, emphasizing long-term founder relationships and impact-focused outcomes beyond traditional financial returns. Historical portfolio investments have included companies in media and information services, such as FocusVision Worldwide and The Pennysaver.
The firm operates within an active co-investment ecosystem, regularly syndicating deals with other institutional capital providers including IMM Investment, which holds a substantial percentage of overlapping portfolio positions. This syndication approach suggests that SV Investment functions both as a lead investor and as a capital partner in larger rounds, leveraging relationships across the venture and private equity communities to structure investments that meet institutional scale and due diligence requirements.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.